BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 3028785)

  • 1. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Meyer P
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF; Hollenberg NK; Graves SW
    Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of human urine-derived digitalis-like factor.
    Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
    Biochem Biophys Res Commun; 1988 Aug; 154(3):847-53. PubMed ID: 2841934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and clinical studies of endogenous digitalis-like factor in hypertension.
    Cloix JF; Devynck MA; Meyer P
    Ann N Y Acad Sci; 1986; 488():217-27. PubMed ID: 2437846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
    Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
    Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human urine-derived digitalis-like factor on cultured renal tubular epithelial cells.
    Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
    J Hypertens Suppl; 1988 Dec; 6(4):S287-9. PubMed ID: 2853736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate.
    Tao QF; Hollenberg NK; Price DA; Graves SW
    Hypertension; 1997 Mar; 29(3):815-21. PubMed ID: 9052901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
    Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
    Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory action of peruvoside and neriifolin on Na+, K(+)-ATPase].
    Ye YX; Yang XR
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):491-4. PubMed ID: 1966653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATPase activity of saponin-treated rat erythrocytes: regulation by monovalent cations, calcium, ouabain, and furosemide.
    Petrunyaka VV; Panyushkina EA; Severina EP; Orlov SN
    Biochim Biophys Acta; 1990 Dec; 1030(2):279-88. PubMed ID: 2175654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.